(Press-News.org) A new study has identified potential broad-spectrum antiviral agents that can target multiple families of RNA viruses that continue to pose a significant threat for future pandemics. The study, led by Gustavo Garcia Jr. in the UCLA Department of Molecular and Medical Pharmacology, tested a library of innate immune agonists that work by targeting pathogen recognition receptors, and found several agents that showed promise, including one that exhibited potent antiviral activity against members of RNA viral families.
The ongoing SARS-CoV-2 pandemic, which has claimed nearly seven million lives globally since it began, has revealed the vulnerabilities of human society to a large-scale outbreak from emerging pathogens. While accurately predicting what will trigger the next pandemic, the authors say recent epidemics as well as global climate change and the continuously evolving nature of the RNA genome indicate that arboviruses, viruses spread by arthropods such as mosquitoes, are prime candidates. These include such as Chikungunya virus (CHIKV), Dengue virus, West Nile virus and Zika virus. The researchers write: “Given their already-demonstrated epidemic potential, finding effective broad-spectrum treatments against these viruses is of the utmost importance as they become potential agents for pandemics.”
In their new study, published in Cell Reports Medicine, researchers found that several antivirals inhibited these arboviruses to varying degrees. “The most potent and broad-spectrum antiviral agents identified in the study were cyclic dinucleotide (CDN) STING agonists, which also hold promise in triggering an immune defense against cancer,” said senior author Vaithi Arumugaswami, Associate Professor in the UCLA Department of Molecular and Medical Pharmacology.
“A robust host antiviral response induced by a single dose treatment of STING agonist cAIMP is effective in preventing and mitigating the debilitating viral arthritis caused by Chikungunya virus in a mouse model. This is a very promising treatment modality as Chikungunya virus-affected individuals suffer from viral arthritis years and decades from the initial infection,” Arumugaswami added.
“At molecular level, CHIKV contributes to robust transcriptional (and chemical) imbalances in infected skin cells (fibroblasts) compared to West Nile Virus and ZIKA Virus, reflecting a possible difference in the viral-mediated injury (disease pathogenesis) mechanisms by viruses belonging to different families despite all being mosquito-borne viruses,” said senior author Arunachalam Ramaiah, Senior Scientist in the City of Milwaukee Health Department.
“The study of transcriptional changes in host cells reveals that cAIMP treatment rescues (reverses) cells from the harmful effect of CHIKV-induced dysregulation of cell repair, immune, and metabolic pathways,” Ramaiah added.
The study concludes that the STING agonists exhibited broad-spectrum antiviral activity against both arthropod-borne- and respiratory viruses, including treaded SARS-CoV-2 and Enterovirus D68 in cell culture models.
Garcia notes, “The next step is to develop these broad-spectrum antivirals in combination with other existing antivirals and be made readily available in the event of future respiratory and arboviral disease outbreaks.”
AUTHORS The study’s first author is Gustavo Garcia Jr., a (former) UCLA Staff Research Associate, and the co-first author is Joseph Ignatius Irudayam, a (former) UCLA Project Scientist. Corresponding authors are Vaithilingaraja Arumugaswami, a UCLA associate professor of molecular and medical pharmacology, a member of the UCLA Broad Stem Cell Research Center, and a member of the California NanoSystems Institute at UCLA, and Arunachalam Ramaiah of the City of Milwaukee Health Department. Other authors are Arjit Vijey Jeyachandran, Swati Dubey, Christina Chang, Sebastian Castillo Cario, Nate Price, Angelica L. Marquez, Aayushi Shah, Amir Fanaei, Nikhil Chakravarty, Shantanu Joshi, Samuel W. French, all of UCLA; Sathya Arumugam of Government College Daman, India; Sanjeev Sinha of All India Institute of Medical Sciences, India and Mark S. Parcells of University of Delaware.
ARTICLE: Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses, Cell Reports Medicine. DOI: https://doi.org/10.1016/j.xcrm.2023.101024
SUPPORT This study is supported by National Institute of Health awards 1R01EY032149-01, 5R01AI163216-02 and 1R01DK132735-01 to Vaithi Arumugaswami.
END
Scientists identify antivirals that could combat emerging infectious diseases
2023-04-28
ELSE PRESS RELEASES FROM THIS DATE:
Study finds ChatGTP outperforms physicians in providing high-quality, empathetic advice to patient questions
2023-04-28
La Jolla, Calif. (April 28, 2023) — There has been widespread speculation about how advances in artificial intelligence (AI) assistants like ChatGPT could be used in medicine.
A new study published in JAMA Internal Medicine led by Dr. John W. Ayers from the Qualcomm Institute within the University of California San Diego provides an early glimpse into the role that AI assistants could play in medicine. The study compared written responses from physicians and those from ChatGPT to real-world health questions. A panel of licensed healthcare professionals preferred ChatGPT’s responses 79% of the time and rated ChatGPT’s responses as higher quality ...
Structured exploration allows biological brains to learn faster than AI
2023-04-28
Neuroscientists have uncovered how exploratory actions enable animals to learn their spatial environment more efficiently. Their findings could help build better AI agents that can learn faster and require less experience.
Researchers at the Sainsbury Wellcome Centre and Gatsby Computational Neuroscience Unit at UCL found the instinctual exploratory runs that animals carry out are not random. These purposeful actions allow mice to learn a map of the world efficiently. The study, published today in Neuron, describes how ...
Health care utilization during the pandemic among individuals born preterm
2023-04-28
About The Study: The findings of this study suggest that during the COVID-19 pandemic, children and young adults born preterm were more likely to have used health care related to COVID-19 concerns compared with their term-born peers, independent of a history of bronchopulmonary dysplasia or asthma. Further exploration of factors associated with COVID-19–related health care use may facilitate refinement of care models.
Authors: Elisabeth C. McGowan, M.D., of Brown University in Providence, Rhode Island, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link ...
Comparing physician and AI chatbot responses to patient questions
2023-04-28
About The Study: In this study of 195 randomly drawn patient questions from a social media forum, a team of licensed health care professionals compared physician’s and chatbot’s responses. The chatbot responses were preferred over physician responses and rated significantly higher for both quality and empathy. Further exploration of this technology is warranted in clinical settings, such as using chatbot to draft responses that physicians could then edit. Randomized trials could assess further if using AI assistants might ...
Treatment of children with ADHD
2023-04-28
About The Study: The results of this study of children with parent-reported attention-deficit/hyperactivity disorder (ADHD) suggest that most were not receiving ADHD medications and had never received outpatient mental health care. Gaps in treatment, which were not directly associated with socioeconomic disadvantage, underscore the challenges of improving communication and access to outpatient mental health care for children with ADHD.
Authors: Mark Olfson, M.D., M.P.H., of Columbia University and the New York State Psychiatric ...
Bentley University study shows NIH investment in new drug approvals is comparable to investment by pharmaceutical industry
2023-04-28
BENTLEY UNIVERSITY
The National Institutes of Health (NIH) spent $187 billion for basic or applied research related to 354 of the 356 drugs approved by the FDA from 2010-2019, according to a new study from Bentley University’s Center for Integration of Science and Industry. The study, published in JAMA Health Forum, shows that the amount invested per approved drug by the NIH is comparable to that of reported investment by the biopharmaceutical industry. The article, titled “Comparison of research spending on new drug approvals by the U.S. National Institutes of Health versus industry, 2010-2019,” is the first to compare the total value of NIH and ...
Six-fold increase in rural cancer screenings with remote outreach
2023-04-28
COLUMBUS – Rural women are six times more likely to get timely breast, cervical and colorectal cancer screening with remote outreach that involves interactive education and follow-up support by telephone, according to a new study.
Through the Rural Interventions for Screening Effectiveness (RISE) study, researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute along with researchers with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center compared the effectiveness ...
Artificial photosynthesis for environmentally friendly food production
2023-04-28
Artificial photosynthesis for environmentally friendly food production
TUM researchers produce important amino acid from greenhouse gas CO2
Growing demand for food in the world
Biotechnological process via methanol as intermediate product
Less ground required than for plant cultivation
Ensuring the supply of food to the constantly growing world population and protecting the environment at the same time are often conflicting objectives. Now researchers at the Technical University of Munich (TUM) have successfully developed ...
British Ecological Society announces journal prize winners
2023-04-28
Today the British Ecological Society (BES) has announced the winners of its journal prizes for research published in 2022. The prizes are awarded for the best paper by an early career researcher in seven of the BES journals: Journal of Applied Ecology, Ecological Solutions and Evidence, Functional Ecology, People and Nature, Methods in Ecology and Evolution, Journal of Ecology and Journal of Animal Ecology.
The winning papers are selected by the Senior Editors of the journals and the awards will be presented to the winners at the BES Annual Meeting in Belfast at the end of the year.
The winners receive a prize of £250, membership of the BES, a year’s subscription to ...
Cause of heart damage from cancer drugs identified
2023-04-28
Safer cancer drugs are now one step closer after a new study led by UCL (University College London) researchers found the likely reason that some treatments damage the heart.
Modern drugs can be very effective at treating cancer and have led to greatly improved survival rates. However, some cancer treatments can cause damage to the heart, or cardiotoxicity. This damage can present in a range of ways, from a slight change in the heart’s pumping ability to debilitating heart failure. But the ways in which these drugs cause damage ...